Growth rate of hepatocellular carcinoma - Evaluation with serial computed tomography or magnetic resonance imaging

被引:68
作者
Taouli, B
Goh, JSK
Lu, Y
Qayyum, A
Yeh, BM
Merriman, RB
Coakley, FV
机构
[1] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Med, Div Gastroenterol, San Francisco, CA USA
关键词
liver neoplasms; computed tomography; magnetic resonance imaging; liver; cirrhosis;
D O I
10.1097/01.rct.0000164036.85327.05
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective: To evaluate the growth rate of untreated hepatocellular carcinoma (HCC) by calculating tumor volume doubling time (TVDT) on serial computed totnography (CT) or magnetic resonance imaging (MR]) and to predict TVDT based on initial tumor size. Methods: Sixteen untreated HCCs in 11 patients with cirrhosis who underwent serial CT or MRI at our institution were retrospectively identified. Two independent readers recorded bidimensional measurements for all tumors, which were used to determine tumor volume (TV). Growth rate was expressed as TVDT. A mathematic model was used to predict TVDT based on baseline tumor size. Results: Mean baseline and follow-up TVs were 10.5 cm(3) (range: 0.7-243.6 cm(3)) and 22.0 cm(3) (range: 2.5-870.8 cm(3)), respectively. Mean duration of follow-up was 176 days (range: 76-472 days). Mean TVDT was 127 days (95% confidence interval: 80, 203; range: 17.5-541.4 days). Expected TVDT could be expressed as TVDT = 114 X (baseline volume) (0.14) (P < 0.002). Conclusion: The results of this study suggest a preferred interval follow-up of approximately 4.5 months (127 days) for HCC screening. Small HCCs show a tendency toward faster growth and may require shorter follow-up to demonstrate progression.
引用
收藏
页码:425 / 429
页数:5
相关论文
共 30 条
  • [1] Arguedas MR, 2003, AM J GASTROENTEROL, V98, P679, DOI 10.1111/j.1572-0241.2003.07327.x
  • [2] NATURAL-HISTORY OF SMALL UNTREATED HEPATOCELLULAR-CARCINOMA IN CIRRHOSIS - A MULTIVARIATE-ANALYSIS OF PROGNOSTIC FACTORS OF TUMOR-GROWTH RATE AND PATIENT SURVIVAL
    BARBARA, L
    BENZI, G
    GAIANI, S
    FUSCONI, F
    ZIRONI, G
    SIRINGO, S
    RIGAMONTI, A
    BARBARA, C
    GRIGIONI, W
    MAZZIOTTI, A
    BOLONDI, L
    [J]. HEPATOLOGY, 1992, 16 (01) : 132 - 137
  • [3] Hepatocellular carcinoma: Evaluation with biphasic, contrast-enhanced, helical CT
    Baron, RL
    Oliver, JH
    Dodd, GD
    Nalesnik, M
    Holbert, BL
    Carr, B
    [J]. RADIOLOGY, 1996, 199 (02) : 505 - 511
  • [4] Helical CT screening for hepatocellular carcinoma in patients with cirrhosis: Frequency and causes of false-positive interpretation.
    Brancatelli, G
    Baron, RL
    Peterson, MS
    Marsh, W
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2003, 180 (04) : 1007 - 1014
  • [5] HEPATOCELLULAR-CARCINOMA IN ITALIAN PATIENTS WITH CIRRHOSIS
    COLOMBO, M
    DEFRANCHIS, R
    DELNINNO, E
    SANGIOVANNI, A
    DEFAZIO, C
    TOMMASINI, M
    DONATO, MF
    PIVA, A
    DICARLO, V
    DIOGUARDI, N
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (10) : 675 - 680
  • [6] NATURAL-HISTORY OF MINUTE HEPATOCELLULAR-CARCINOMA SMALLER THAN .3. CENTIMETERS COMPLICATING CIRRHOSIS - A STUDY IN 22 PATIENTS
    EBARA, M
    OHTO, M
    SHINAGAWA, T
    SUGIURA, N
    KIMURA, K
    MATSUTANI, S
    MORITA, M
    SAISHO, H
    TSUCHIYA, Y
    OKUDA, K
    [J]. GASTROENTEROLOGY, 1986, 90 (02) : 289 - 298
  • [7] Ebara M, 1998, HEPATO-GASTROENTEROL, V45, P1214
  • [8] Rising incidence of hepatocellular carcinoma in the United States
    El-Serag, HB
    Mason, AC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (10) : 745 - 750
  • [9] Resection or transplantation for hepatocellular carcinoma in cirrhotic patients: Outcomes based on indicated treatment strategy
    Figueras, J
    Jaurrieta, E
    Valls, C
    Ramos, E
    Serrano, T
    Rafecas, A
    Fabregat, J
    Torras, J
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2000, 190 (05) : 580 - 587
  • [10] HAVELAAR IJ, 1984, CANCER, V54, P163, DOI 10.1002/1097-0142(19840701)54:1<163::AID-CNCR2820540131>3.0.CO